Skip to main content
An official website of the United States government

Subhashini Jagu

Headshot of Indian woman (Dr. Subhashini Jagu) with hair tied back in a ponytail, wearing a white shirt in front of a white background.

Dr. Subhashini Jagu believes CCDI’s team science approach can accelerate new developments in childhood cancer research and treatments.

Credit: National Cancer Institute
  • Chief, Scientific Policy and Program Branch A
  • Supervisory Health Scientist Administrator, Office of Data Sharing at NCI

As a farmer’s daughter, Dr. Subhashini Jagu (she/her) often draws parallels between agriculture and research. “They’re similar because neither provides immediate results,” she says. “It takes time to see the products of your labor.”

Subhashini, who oversees data sharing and accessibility efforts at NCI, sees CCDI as a model of team science—researchers, providers, patients, and families working together toward a common goal. Sharing data and experiences within such a network has the potential to spark new developments in childhood cancer research and treatments.

One crucial ember from that spark is CCDI’s Molecular Characterization Initiative (MCI). MCI helps the very patients who motivate Subhashini by using state-of-the-art testing to provide a more precise diagnosis. “MCI is very unique, and we’re learning a lot about predicting drug effectiveness and how clinicians use testing data in real time to make treatment recommendations,” she says.

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Subhashini Jagu was originally published by the National Cancer Institute.”

Email